Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > One BIG Step in the Right Direction
View:
Post by Smokey1958 on Jan 31, 2022 9:14am

One BIG Step in the Right Direction

Not much left to happen now! Please don't complain about the news when there have been some who have constantly complained about the lack of it. The testing is COMPLETED. This means the AcuVid component is done and they await the final PCR results to match against these. Even in challenging times that should happen this week. I would expect FDA submission by the end of the week. Once those PCR results are in they could write and submit a report within hours.

Also, Rob would not continue to present such a positive and optimistic sentiment if the results thus far were poor. Again, I would expect they're great.

GLTE!!!!
Comment by Newcastle on Jan 31, 2022 9:19am
AGREED:  in the NR "we are confident that our AcuVid™ U.S. Clinical Performance Study will meet the Emergency Use Authorization's (EUA) rigorous review. We will submit the U.S Clinical Performance Study data to the FDA once it is collected and tabulated."
Comment by terr2 on Jan 31, 2022 9:41am
For this thing to take off, time lines have got to be met much better than previous times. There is very little faith left in Fia's ability to execute swiftly. JMO
Comment by Stockings8 on Jan 31, 2022 9:44am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities